OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An updated patent review of Nrf2 activators (2020-present)
Ziquan Zhao, Ruitian Dong, Keni Cui, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 1, pp. 29-49
Closed Access | Times Cited: 15

Showing 15 citing articles:

Understanding mechanisms of antioxidant action in health and disease
Barry Halliwell
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 1, pp. 13-33
Closed Access | Times Cited: 222

Advances in developing noncovalent small molecules targeting Keap1
Marilia Barreca, Yuting Qin, M Cadot, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103800-103800
Open Access | Times Cited: 16

NRF2-mediated regulation of lipid pathways in viral infection
Khursheed Muzammil, Zahraa Sabah Ghnim, Ibrahim Saeed Gataa, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101279-101279
Closed Access | Times Cited: 7

Targeting Nrf2 by bioactive peptides alleviate inflammation: expanding the role of gut microbiota and metabolites
Zhongxing Chu, Lingfeng Zhu, Yaping Zhou, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-20
Closed Access | Times Cited: 5

Patenting perspective on Keap1 inhibitors (2019-2024)
Yue Luo, Wenlong Yang, Yuan Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access

The role of NRF2 function and regulation in atherosclerosis: an update
Siarhei A. Dabravolski, Alexey V. Churov, Dmitry F. Beloyartsev, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access

Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Protein–Protein Interaction Inhibitors
Ziquan Zhao, Ruitian Dong, Qidong You, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9325-9344
Closed Access | Times Cited: 11

Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives
Yangguo Zhou, Qiong Zhang, Ziquan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116270-116270
Closed Access | Times Cited: 3

Vitexin and isovitexin delayed ageing and enhanced stress-resistance through the activation of the SKN-1/Nrf2 signaling pathway
Mingfang Tao, Rong Li, Tingting Xu, et al.
International Journal of Food Sciences and Nutrition (2023) Vol. 74, Iss. 6, pp. 685-694
Open Access | Times Cited: 4

Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response
Mengchen Lu, Jianai Ji, Yifei Lv, et al.
Cell chemical biology (2023) Vol. 31, Iss. 6, pp. 1188-1202.e10
Closed Access | Times Cited: 4

Allicin attenuates the oxidative damage induced by Aflatoxin B1 in dairy cow hepatocytes via the Nrf2 signalling pathway
Xin Jin, Chenlong Wang, Chuangjiang Chen, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 280, pp. 116527-116527
Open Access | Times Cited: 1

State‐of‐the‐art Nrf2 Inhibitors: Therapeutic Opportunities in Non‐cancer Diseases
Emil G. Ayala‐Cosme, Deborah J. Yang, Kyara Vences, et al.
ChemMedChem (2024)
Closed Access

Page 1

Scroll to top